Global Automated Immunoassay Analyzers Market Projected To Expand At Over 16.1% CAGR During 2020–2026

As per the Zion Market Research analysts, the global automated immunoassay analyzers market was capitalized at more than USD 11.02 billion in 2019 and is projected to expand at a CAGR of over 16.1% during the forecast period. A few of the prominent players in the global automated immunoassay analyzers market consist of Biokit, Siemens Healthcare, Abbott Diagnostics, Luminex Corporation, Biomerieux, and Roche Diagnostics. The key approaches implemented by the market participants comprise introducing technologically sophisticated and pioneering products. Also, they emphasize the expansion of product range to fulfill the needs of diverse lab settings taking into consideration the assay menu, budget, test volumes, and automation level to remain at the forefront of the competition.

Rising Disease Epidemics Is Likely To Propel The Demand For Automated Immunoassay Analyzers

The expansion of the global automated immunoassay analyzers market is mainly propelled by the rising occurrence of disease outbreaks like Zika and the rising incidence of chronic diseases like hepatitis. Furthermore, the trends of laboratory automation & integration along with preventive healthcare are other few factors that are generating avenues for the expansion of the global automated immunoassay analyzers market. In addition, the increasing need for international standardization and result comparability is also anticipated to result in the rapid adoption of automated immunoassay analyzers. Also, the rapid implementation of sophisticated technologies is projected to play a vital role in the immunoassay analyzers market expansion during the coming years. Conversely, cost restraints, particularly among smaller diagnostic laboratories is restricting the implementation of automated immunoassay analyzers. In the meantime, diagnostic labs in developed markets might confront challenges owing to declining reimbursements.

Chemiluminescence Immunoassay Analyzers Segment To Witness Substantial Growth

In 2018, the biggest share in the market was held by the chemiluminescence immunoassay analyzers segment. This expansion can be credited to the rising usage as a result of its high accuracy and sensitivity of analyte detection leading to a precise diagnosis. The greater veracity and receptiveness of chemiluminescence immunoassay drives the expansion of the automated immunoassay analyzers market.

North America Expected To Maintain Its Dominance In The Global Market During Forecast Period

In 2018, the global automated immunoassay analyzers market was dominated by North America, particularly the U.S. and is expected to maintain its supremacy over the forecast period. The laboratory automation has considerably decreased the time and cost needed for lab operations because of that automated devices within labs are progressively preferred more in the US. Further, the rising implementation for lab automation technologies is anticipated to drive the market growth in the years to come. Further, China automated immunoassay analyzers market is projected to observe noteworthy expansion at around 18.5% CAGR during the forecast period. Suitable government programs like the adoption of the national project in 2008, targeted at enhancing the control and prevention of infectious diseases are expected to propel China automated immunoassay analyzers market.

Browse the full “Global Automated Immunoassay Analyzers Market - By Sales Model (Outright Sale and Reagent Rental/Lease), By Technology (Enzyme-Linked Fluorescent Immunoassay (ELFA), Chemiluminescence Immunoassay (CLIA), Radioimmunoassay (RIA), and Enzyme-Linked Immunosorbent Assay (ELISA)), By End-User (Diagnostic Laboratories, Hospitals, and Blood Bank), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026.” Report at https://www.zionmarketresearch.com/report/automated-immunoassay-analysers-market

The global automated immunoassay analyzers market is segmented as follows:

By Technology

• Chemiluminescence Immunoassay (CLIA)
• Enzyme-Linked Fluorescent Immunoassay (ELFA)
• Enzyme-linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• Others (Biochip Assay, Immunofluorescent Assay, and Counting Assay)

By Sales Model

• Reagent Rental / Lease
• Outright Sale

By End-User

• Hospitals
• Diagnostic Laboratories
• Blood Banks
• Others (Research Institutes, Pharmaceutical & Biotechnology Industry, Food & Beverages Industry)

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com